a-rod doc

Updated: MLB investigating Alex Rodriguez’s link with new doctor


A new player suddenly emerged in the bizarre Alex Rodriguez saga on Wednesday when Dr. Michael L. Gross and told Mike Francesa on WFAN that he had reviewed A-Rod’s MRI and detected no quad injury. In so doing, he contradicted the diagnosis of a Grade 1 quad strain from Yankees doctor Christopher Ahmad.

Reports have since indicated that Rodriguez gave the doctor permission to talk to the media, which has led some to believe that Rodriguez is trying to force the Yankees’ hands and get back into the lineup. Other reports have made it clear that Rodriguez needed Yankees approval to receive a second opinion and never got it, meaning he’s broken a rule from the CBA.

But Gross is a mystery in all this. From the New York Daily News:

According to a source with close knowledge of the situation, however, the Yankees have never heard of Gross, and do not believe Gross examined the same MRI looked at by Ahmad on Sunday after Rodriguez complained for the second straight week of quad tightness.

Further, said the source, New York Presbyterian Hospital did not release results from the MRI it conducted on Rodriguez and the Yankees do not believe he was examined by Gross.

If that’s the case, then perhaps A-Rod didn’t get an official second opinion and is in the clear, at least in that regards.

But what about Gross? He’s listed as a graduate of the New York University School of Medicine and as an orthopedic surgeon for Hackensack UMC. He’s also the the Co-Founder and Medical Director of the Active Center for Health & Wellness, located in Hackensack, New Jersey. According to its website, the top program offered by the place is “Anti-Aging & Bio-Identical Hormone Replacement Therapy.”

Gross’s own bio states that he’s “he is currently enrolled in a fellowship in anti-aging and restorative medicine and is working towards board certification form the American Academy of Anti-Aging Medicine.” And the New York Daily News is now reporting that Gross was reprimanded by the New Jersey Attorney General earlier this year for “failing to adequately ensure proper patience treatment involving the prescribing of hormones, including steroids.”

The NYDN further goes on to say that MLB is already investigating A-Rod’s relationship with the doctor.

Gross says the reprimand was the result of an innocent mistake:

“One of the people who worked [at the Active Center for Health & Wellness] was a physician who completed medical school, who finished a residency, but he wasn’t a licensed physician in New Jersey. We never maintained that he was a physician, but in an unrelated investigation of a lot of wellness centers, the board came across that,” Gross said on SNY. “I met with the board. I received what you saw. It’s a closed matter. But it has nothing to do with Alex. I really don’t think it’s germane to this. (Rodriguez) has never been a patient here. He’s never been treated here. We don’t prescribe anabolic steroids. We never have. We prescribe what’s called bio-identical hormones, for men with low testosterone, like what you see on television all the time. We prescribe testosterone.”

MLB won’t like that much, either. One of the things Anthony Bosch was known to offer at Biogenesis were testosterone troches, which are lozenges that were placed under the tongue. Even if Rodriguez has never set foot in the Active Center for Health & Wellness, the association was a bad idea.


Update: Yankees GM Brian Cashman has issued a statement on the Rodriguez situation. Here it is in full:

“I heard via a text message this afternoon from Alex Rodriguez that he had retained a doctor to review his medical situation. In media reports, we have since learned that the doctor in question has acknowledged that he did not examine Mr. Rodriguez and that he was not retained to do a comprehensive medical examination of Mr. Rodriguez. Contrary to the Basic Agreement, Mr. Rodriguez did not notify us at any time that he was seeking a second opinion from any doctor with regard to his quad strain.

“As you know, it is the Yankees’ desire to have Alex return to the lineup as soon as possible. And we have done everything to try and accomplish this.

“As early as Friday, July 12, when I suggested to Alex that we move his rehab from Tampa to Triple-A Scranton (at Buffalo), Alex complained for the first time of “tightness” in his quad and therefore refused to consent to the transfer of his assignment. Again, last Sunday, Alex advised that he had stiffness in his quad and should not play on Sunday or Monday. We sent Alex to NewYork-Presbyterian Hospital for an MRI which evidenced a Grade 1 strain.

“As always, we will follow the rules and regulations set forth in the Basic Agreement, and will again re-evaluate Alex in Tampa tomorrow, as our goal is to return him to the lineup as soon as he is medically capable of doing so.”

Mariners interested in free agent outfielder Nori Aoki

AP Photo/Ben Margot
Leave a comment

New Mariners general manager Jerry Dipoto has kept pretty busy in his short time on the job and Bob Dutton of the Tacoma News Tribune reports that free agent outfielder Nori Aoki could be his next target. The club recently pursued a trade for Marlins outfielder Marcell Ozuna, but the asking price has them looking at alternatives.

Aoki, who turns 34 in January, has hit .287 with a .353 on-base percentage over four seasons since coming over from Japan. He was having a fine season with the Giants this year prior to being shut down in September with lingering concussion symptoms.

The Giants decided against picking up Aoki’s $5.5 million club option for 2016 earlier this month, but he should still do pretty well for himself this winter assuming he’s feeling good.

Report: Johnny Cueto is believed to be looking for a $140-160 million deal

AP Photo/Matt Slocum
Leave a comment

It was reported Sunday that free agent right-hander Johnny Cueto had turned down a six-year, $120 million contract from the Diamondbacks. He’s hoping to land a bigger deal this winter and ESPN’s Jerry Crasnick has heard some chatter about what he’s looking for.

Jordan Zimmermann finalized a five-year, $110 million contract with the Tigers today, which works out to $22 million per season. Arizona’s offer to Cueto checked in at $20 million per season. A six-year offer to Cueto at the same AAV (average annual value) as Zimmermann would put him at $132 million, which is still a little shy of the figure stated by Crasnick. Of course, Cueto owns a 2.71 ERA (145 ERA+) over the last five seasons compared to a 3.14 ERA (123 ERA+) by Zimmermann during that same timespan, so there’s a case to be made that he should get more. Still, he’s the clear No. 3 starter on the market behind David Price and Zack Greinke.

CBS Sports’ Jon Heyman reports that the Dodgers, Giants, Red Sox, and Cubs are among the other teams who have interest in Cueto. One variable in his favor is that he is not attached to draft pick compensation, as he was traded from the Reds to the Royals during the 2015 season.

Report: Around 20 teams have contacted the Braves about Shelby Miller

AP Photo/John Bazemore
Leave a comment

The rebuilding Braves have already been active on the trade market and they might not be done, as CBS Sports’ Jon Heyman reports that right-hander Shelby Miller has been a very popular name. In fact, around 20 teams have checked in.

Nothing is considered close and the Braves have set a very high asking price, mostly centered around offense. They asked for right-hander Luis Severino in talks with the Yankees and would expect outfielder Marcell Ozuna among other pieces from the Marlins. The Diamondbacks and Giants are among the other interested clubs.

Miller is under team control through 2018, so there’s not necessarily a sense of urgency to move him, but anything is possible with the way the Braves are doing things right now. The 25-year-old is coming off a year where he went 6-17, but that was about really rotten luck more than anything else, as he had a fine 3.02 ERA and 171/73 K/BB ratio over 205 1/3 innings. The Braves gave him the worst run support of any starter in the majors.

Mets expected to tender a contract to Jenrry Mejia

NEW YORK, NY - JULY 12:  Jenrry Mejia #58 of the New York Mets reacts as he walks off the field after getting the final out of the seventh inning against the Arizona Diamondbacks at Citi Field on July 12, 2015 in the Flushing neighborhood of the Queens borough of New York City.  (Photo by Jim McIsaac/Getty Images)
Photo by Jim McIsaac/Getty Images

Jenrry Mejia appeared in just seven games this past season due to a pair of suspensions for performance-enhancing drugs, but Adam Rubin of ESPN New York reports that the Mets are expected to tender him a contract for 2016.

While the Mets were vocal about their disappointment in Mejia’s actions, it makes sense to keep him around as an option. Had he played a full season in 2015, he would have earned $2.595 million. He’s arbitration-eligible for the second time this winter and figures to receive a contract similar to his 2015 figure, but he’ll only be paid for the games he plays. He still has 100 games to serve on his second PED suspension, which means that he’ll only be paid for 62 games in 2016. This likely puts his salary closer to $1 million, which is a small price to pay for someone who could prove useful during the second half and beyond. He also won’t count toward the team’s 40-man roster until he’s active.

Mejia, who turned 26 in October, owns a 3.68 ERA in the majors and saved 28 games for the Mets in 2014. He’s currently pitching as a starter in the Dominican Winter League.